Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BIYA vs WOK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BIYA Captures Overall Composite Edge (52.3 HOLD vs 25.6 SELL), While WOK Leads 3–2 on Growth & Valuation Pillars

BIYA Overall Winner 6-Pillar Tally: BIYA 2 – 3 WOK (1 Tie) Matrix Metrics: BIYA 4 – 3 WOK

As of Nov 16, 2026, Baiya International Group Inc. (BIYA) captures the overall head-to-head institutional edge over WORK Medical Technology Group LTD Class A (WOK) on higher Unified Composite conviction (52.3/100 HOLD vs. 25.6/100 SELL) after splitting the core matrix 4–3 (led by Valuation Multiples, Growth & Scale), while WOK wins 3–2 across the 6-pillar growth and valuation breakdown. BIYA trades at $1.21 (N/M Forward P/E, -45.7% operating margin) versus WOK at $1.23 (N/M Forward P/E, -41.7% operating margin).

  • Growth vs. Quality Trade-Off: BIYA earns the overall head-to-head edge with a stronger Unified Composite Score (52.3/100 HOLD vs. WOK 25.6/100 SELL) and -6.11β · 39% Vol risk profile, whereas WOK leads top-line expansion (+19.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: BIYA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.7); meanwhile WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BIYA vs WOK
BIYA NASDAQ Head-to-Head Winner
Baiya International Group Inc. Ordinary Shares
Services-Employment Agencies
$1.21
+0.0% 1D
Market Cap $8.3M
TTM Revenue $17M
Forward P/E N/M
Beta / 30D Vol -6.11β · 39% Vol
Unified Composite Score
52.3 / 100 HOLD
Tech 49.0 Fund 70.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -23.2%), weak momentum, RSI 40
RSI-14: 39.7 · SMA20: $1.21 · SMA50: $1.61
WOK NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap $5.4M
TTM Revenue $11M
Forward P/E N/M
Beta / 30D Vol 38.49β · 153% Vol
Unified Composite Score
25.6 / 100 SELL
Tech 5.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $1.13 · SMA50: $1.47

6-Pillar Scorecard Institutional Category Breakdown (BIYA 2 – 3 WOK)

Columns: Metric · BIYA · WOK
1. Valuation Multiples BIYA
Forward P/E N/M N/M
Trailing P/E 0.0x N/M
PEG Ratio N/M N/M
EV / Revenue 0.5x 0.5x
2. Growth & Scale BIYA
Revenue Growth (YoY) +53.2% +19.1%
Earnings Growth (YoY) +0.0% -95.0%
TTM Revenue (USD) $17M $11M
Market Cap $8.3M $5.4M
3. Profitability & Quality WOK
Gross Margin 11.5% 17.0%
Operating Margin -45.7% -41.7%
Net Profit Margin -41.8% -41.9%
Return on Equity (ROE) -30.8% -19.2%
4. Balance Sheet & Cash Flow WOK
Cash Generation (TTM) -$7.9M EBITDA -$3.4M EBITDA
Cash Flow Margin -45.7% EBITDA Mgn -31.4% EBITDA Mgn
Net Cash / Leverage $4.33 Book/Sh · -30.8% ROE $1855.16 Book/Sh · -19.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat WOK
OpEx & R&D Intensity 57.2% of Rev ($9.9M) 58.7% of Rev ($6.3M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BIYA (4) vs WOK (3)
Institutional Metric BIYA WOK Criterion Row Edge
Market Capitalization
Scale
$8.3M $5.4M Larger Scale Tie
Trailing P/E Ratio
Valuation
0.0x N/M Lower Multiple BIYA
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+53.2% +19.1% Higher Growth BIYA
Operating Margin (TTM)
Profitability
-45.7% -41.7% Higher Margin WOK
Net Profit Margin
Profitability
-41.8% -41.9% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-30.8% -19.2% Higher ROE WOK
52-Week Range Position
Momentum
11% ($0–$10) 16% ($0–$7) Stronger Trend WOK
Beta / 30D Volatility
Risk Regime
-6.11β · 39% Vol 38.49β · 153% Vol Lower Realized Risk BIYA
Unified Institutional Score
Composite Signal
52.3 / 100 (HOLD) 25.6 / 100 (SELL) Higher Composite BIYA
Trailing 12M Revenue (USD)
Operating Scale
$17M $11M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
11.5% 17.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · 0.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.9M EBITDA ($4.33 Book/Sh · -30.8% ROE) -$3.4M EBITDA ($1855.16 Book/Sh · -19.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WOK +19.76 pp
BIYA: -6.92% · WOK: +12.84%
3M Horizon WOK +7.51 pp
BIYA: -51.6% · WOK: -44.09%
6M Horizon WOK +194.96 pp
BIYA: +28.72% · WOK: +223.68%
1Y Horizon BIYA +340.95 pp
BIYA: +268.9% · WOK: -72.05%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIYA vs WOK. Trailing 12-month operating profitability (BIYA -45.7% vs WOK -41.7%) and valuation multiples (BIYA N/M vs WOK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BIYA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$17M
Gross Margin11.5%
Op. Margin-45.7%
ROE / Fwd P/E-30.8% · N/M
WOK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$11M
Gross Margin17.0%
Op. Margin-41.7%
ROE / Fwd P/E-19.2% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BIYA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BIYA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WOK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WOK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BIYA Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $8.3M market capitalization and -45.7% operating margin.
OpEx & R&D Reinvestment 57.2% of Rev ($9.9M)
90D Engineering Disclosures 0 Published
WOK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $5.4M market capitalization and -41.7% operating margin.
OpEx & R&D Reinvestment 58.7% of Rev ($6.3M)
90D Engineering Disclosures 0 Published

Investor FAQ BIYA vs WOK Key Questions & Quantitative Answers

As of Nov 16, 2026, Baiya International Group Inc. (BIYA) captures the overall head-to-head institutional edge over WORK Medical Technology Group LTD Class A (WOK) on higher Unified Composite conviction (52.3/100 HOLD vs. 25.6/100 SELL) after splitting the core matrix 4–3 (led by Valuation Multiples, Growth & Scale), while WOK wins 3–2 across the 6-pillar growth and valuation breakdown. BIYA trades at $1.21 (N/M Forward P/E, -45.7% operating margin) versus WOK at $1.23 (N/M Forward P/E, -41.7% operating margin). Growth vs. Quality Trade-Off: BIYA earns the overall head-to-head edge with a stronger Unified Composite Score (52.3/100 HOLD vs. WOK 25.6/100 SELL) and -6.11β · 39% Vol risk profile, whereas WOK leads top-line expansion (+19.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BIYA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.7); meanwhile WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BIYA leads the Growth & Scale pillar: BIYA posts +53.2% YoY revenue growth and +0.0% YoY earnings growth on $17M TTM revenue (11.5% gross margin, -45.7% operating margin), compared with WOK at +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin). On trailing 12-month operating scale, BIYA generates $17M in USD-normalized revenue versus $11M for WOK. In operating R&D and SG&A reinvestment, BIYA deploys 57.2% of Rev ($9.9M) (0 90-day corporate R&D disclosures) versus 58.7% of Rev ($6.3M) (0 disclosures) for WOK.

BIYA screens cheaper on headline valuation multiples. BIYA trades at N/M Forward P/E, 0.0x Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-45.7% EBITDA margin), whereas WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BIYA (-30.8% ROE) versus WOK (-19.2% ROE) capital efficiency.

In options market volatility and institutional positioning, BIYA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-6.11β · 39% Vol realized risk). By comparison, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Baiya International Group Inc. Ordinary Shares (BIYA) Research Suite

WORK Medical Technology Group LTD Class A Ordinary Shares (WOK) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.